688221Frontier Biotechnologies688221 info
$0.66info3.30%24h
Global rank15945
Market cap$248.64M
Change 7d3.30%
YTD Performance-52.67%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Frontier Biotechnologies (688221) Stock Overview

    Frontier Biotechnologies Inc., a commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patient health. The company's medicines address the unmet medical needs of patients in the areas of anti-HIV treatment and pain management. It offers Aikening, a long-acting HIV fusion inhibitor for the treatment of HIV infection and AIDS. The company's products in development include FB1002, an all-injectable long-acting HIV therapy; FB2001, a SARS-CoV-2 3CL protease inhibitor under clinical development for hospitalized patients as well as for post-exposure prophylaxis of Covid-19; FB3001, a new transdermal topical patch for musculoskeletal joint pain treatment under clinical development; and FB600, an investigational therapeutic peptide vaccine targeting PCSK9 to treat hypercholesterolemia. The company was founded in 2013 and is headquartered in Nanjing, China.

    688221 Stock Information

    Symbol
    688221
    Address
    Building E-2, Greenland WindowNanjing, 211199China
    Founded
    -
    Trading hours
    9:30 AM - 3:00 PM CST
    Website
    https://www.frontierbiotech.com
    Country
    🇨🇳 China
    Phone Number
    86 25 6964 8375

    Frontier Biotechnologies (688221) Price Chart

    -
    Value:-

    Frontier Biotechnologies Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.6637761803211547
    N/A
    Market Cap
    $248.64M
    N/A
    Shares Outstanding
    374.58M
    N/A
    Employees
    495.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org